Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma

INTRODUCTION: Lenalidomide (LEN) is a relatively new and very effective therapy for multiple myeloma (MM). Prior LEN therapy is associated with an increased risk of peripheral blood stem cell collection (PBSC) failure, particularly with filgrastim (G-CSF) alone. We performed a retrospective chart re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bhutani, Divaya, Zonder, Jeffrey, Valent, Jason, Tageja, Nishant, Ayash, Lois, Deol, Abhinav, Al-Kadhimi, Zaid, Abrams, Judith, Lum, Lawrence, Ratanatharathorn, Voravit, Uberti, Joseph, Abidi, Muneer H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837683/
https://ncbi.nlm.nih.gov/pubmed/23591714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-013-1808-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi